MiNK Therapeutics OverviewMiNK Therapeutics Net Income
Profitability analysis for INKT.
Quarterly Net Income
-$2.74B
↑ 0.88% YoY
As of Mar 2026
Annual Net Income (TTM)
-$18.12B
↓ 295.74% YoY
Trailing 12 months ending Mar 2026
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...